Perfusia Biosciences Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Perfusia Biosciences General Information

Description

Developer of a medical technology platform intended for pharmaceutical drug testing. The company's platform allows for implantation and vascular support of various tissues within a microfluidic platform to be used to model a wide range of organs and diseases from brain cancer to drug absorption in the gut, thereby providing hospitals with stem cell-derived vitro disease 3D organ models for assistance in drug discovery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 100 College Street
  • Room 156
  • Toronto, Ontario M5G 1L5
  • Canada
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Perfusia Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jan-2019 Completed Startup
To view Perfusia Biosciences’s complete valuation and funding history, request access »

Perfusia Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The UTEST Program Accelerator/Incubator 000 0000 000000 0
To view Perfusia Biosciences’s complete investors history, request access »